KNOTBODY

Owners

Goods & Services

Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs

Scientific and technological services, namely, scientific research, analysis and testing in the fields of pharmaceuticals, biochemicals, polypeptides, antibodies, ion channel blocking antibodies and antibodies derived from mini-protein toxins; drug discovery services and pharmaceutical drug development services; conducting or providing research and development services for others in the field of antibodies; scientific laboratory services relating to the production of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins

Pharmaceuticals and pharmaceutical preparations for the treatment of diseases and conditions associated with ion channel activity; drug delivery agents in the form of liquid preparations for infusion or injection that facilitate the delivery of pharmaceutical preparations; antibodies for medical use, namely, ion channel blocking antibodies and antibodies derived from mini-protein toxins; pharmaceuticals and pharmaceutical preparations incorporating antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, for the treatment of diseases and conditions associated with ion channel activity

Medical services; medical services connected with the treatment of diseases through the use of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid